ACELRX PHARMACEUTICALS INC Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACELRX PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACELRX PHARMACEUTICALS INC for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2014 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | D | 1.20 | 2,305 | 2,766 | 6,675 | |
Mar 19 2014 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Option Exercise | D | 1.20 | 2,911 | 3,493 | 0 | |
Mar 19 2014 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Sell | D | 12.58 | 1,000 | 12,580 | 52,050 | 53.1 K to 52.1 K (-1.89 %) |
Mar 19 2014 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Grant | A | 1.20 | 5,216 | 6,259 | 53,050 | 47.8 K to 53.1 K (+10.90 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | D | 3.11 | 9,375 | 29,156 | 3,125 | |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Option Exercise | D | 3.25 | 11,666 | 37,915 | 3,334 | |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Sell | D | 12.15 | 21,041 | 255,636 | 60,000 | 81 K to 60 K (-25.96 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Grant | A | 3.11 | 9,375 | 29,156 | 81,041 | 71.7 K to 81 K (+13.08 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | EDWARDS MARK G | Director | Grant | A | 3.25 | 11,666 | 37,915 | 71,666 | 60 K to 71.7 K (+19.44 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Payment of Exercise | F | 11.43 | 1,380 | 15,773 | 22,530 | 23.9 K to 22.5 K (-5.77 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | Dasu Badri N | Chief Engineering O ... | Sell | D | 12.45 | 1,000 | 12,452 | 23,910 | 24.9 K to 23.9 K (-4.01 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | KING RICHARD | Director | Payment of Exercise | F | 11.43 | 11,599 | 132,577 | 134,567 | 146.2 K to 134.6 K (-7.94 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | Hamel Lawrence G | Chief Development O ... | Payment of Exercise | F | 11.43 | 1,569 | 17,934 | 47,834 | 49.4 K to 47.8 K (-3.18 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.36 | 11,250 | 139,050 | 126,153 | 137.4 K to 126.2 K (-8.19 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 11.96 | 459 | 5,490 | 137,403 | 137.9 K to 137.4 K (-0.33 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.39 | 1,759 | 21,791 | 137,862 | 139.6 K to 137.9 K (-1.26 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.36 | 509,520 | 6,297,667 | 5,713,569 | 6.2 M to 5.7 M (-8.19 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 11.96 | 20,800 | 248,768 | 6,223,089 | 6.2 M to 6.2 M (-0.33 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.39 | 79,645 | 986,658 | 6,243,889 | 6.3 M to 6.2 M (-1.26 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.36 | 16,049 | 198,366 | 179,962 | 196 K to 180 K (-8.19 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 11.96 | 655 | 7,834 | 196,011 | 196.7 K to 196 K (-0.33 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.39 | 2,508 | 31,070 | 196,666 | 199.2 K to 196.7 K (-1.26 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.36 | 298,508 | 3,689,559 | 3,347,357 | 3.6 M to 3.3 M (-8.19 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 11.96 | 12,186 | 145,745 | 3,645,865 | 3.7 M to 3.6 M (-0.33 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | WAN MARK A | Director | Sell | S | 12.39 | 46,661 | 578,046 | 3,658,051 | 3.7 M to 3.7 M (-1.26 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | HOFFMAN STEPHEN J | Director | Sell | J | 0.00 | 1,300,000 | 0 | 2,871,933 | 4.2 M to 2.9 M (-31.16 %) |
Mar 11 2014 | ACRX | ACELRX PHARMACEUTI ... | Skyline Venture Partners Quali ... | Sell | J | 0.00 | 1,300,000 | 0 | 2,871,933 | 4.2 M to 2.9 M (-31.16 %) |